Gene · 586
Papers1,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reversal of BCAA-driven inflammatory senescence by traditional herbal oil prevents atopic dermatitis relapse. | Phytomedicine | 2025 | 41161187 | PubTator, text mining | PubMed |
| PTGFRN promotes non-small cell lung cancer malignant progression and reprograms BCAA metabolism by activating STAT3/BCAT1 pathway. | Biochem Pharmacol | 2025 | 41130302 | PubTator, text mining | PubMed |
| ITGB5-mediated biomechanical regulation in pancreatic ductal adenocarcinoma stroma impacts tumor progression and prognosis. | J Transl Med | 2025 | 41121153 | PubTator, text mining | PubMed |
| Deciphering macrophage heterogeneity and factors driving M2 polarization in lung adenocarcinoma through single-cell RNA sequencing. | Apoptosis | 2025 | 41099999 | PubTator, text mining | PubMed |
| Assessing the mechanism of osteosarcoma induced by long-term PET exposure: prediction from combined network toxicology, machine learning and molecular docking. | J Bone Oncol | 2025 | 41070274 | PubTator, text mining | PubMed |
| Genetic architecture of plasma metabolome in 254,825 individuals. | Nat Commun | 2025 | 40973927 | PubTator, text mining | PubMed |
| Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies. | Discov Oncol | 2025 | 40956459 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism. | Cancer Med | 2025 | 40956032 | PubTator, text mining | PubMed |
| Enniatin Mycotoxins in Food: A Systematic Review of Global Occurrence, Biosynthesis, and Toxicological Impacts on In Vitro Human Cell Models. | Compr Rev Food Sci Food Saf | 2025 | 40946203 | PubTator, text mining | PubMed |
| Integrated transcriptome and single-cell RNA sequencing analysis revealed the prognostic significance of GBP4 in pancreatic adenocarcinoma. | Transl Oncol | 2025 | 40944976 | PubTator, text mining | PubMed |
| Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9. | J Clin Invest | 2025 | 40924473 | PubTator, text mining | PubMed |
| The ACSS2-PPARD-BCAT1 axis synchronously regulates branched-chain amino acid metabolism and development in pancreatic cancer. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40908872 | PubTator, text mining | PubMed |
| Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma. | PLoS One | 2025 | 40875626 | PubTator, text mining | PubMed |
| A systematic review of omics discovery studies to identify pertinent metabolic pathways for locally advanced rectal cancer in response to neoadjuvant chemoradiotherapy. | Metabolomics | 2025 | 40839139 | PubTator, text mining | PubMed |
| ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance. | Hepatol Commun | 2025 | 40824254 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| The cytosolic branched-chain amino transferase 1 (BCAT1/BCATc) inhibitor reduces mitochondrial capacity in a myotube model of insulin resistance. | J Endocrinol Invest | 2025 | 40622520 | PubTator, text mining | PubMed |
| Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments. | Carcinogenesis | 2025 | 40482015 | PubTator, text mining | PubMed |
| Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses. | Clin Epigenetics | 2025 | 40468374 | PubTator, text mining | PubMed |
| Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance. | Discov Oncol | 2025 | 40397318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/586/papers?page=4